Humacyte · 1 day ago
Senior Supplier Quality Lead
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues. The Senior Supplier Quality Lead will oversee supplier audits, manage the Raw Materials release and inspection program, and ensure the timely delivery of critical Raw Materials for commercial manufacturing.
BiotechnologyMedicalMedical Device
Responsibilities
Oversee and perform the Raw Material testing program via third-party testing laboratories and contract manufacturers
Oversee and perform the Raw Material release program via the visual inspection process for raw materials and components received for commercial manufacturing
Review and approval of OOS and nonconformance investigations for third-party laboratories
Review and approval of raw material release documentation including receipt paperwork, supplier certificate of analysis, and third-party testing results against internal specifications, as applicable
Review and approve SOPs, protocols, specifications, and reports associated with raw material QC programs / procedures, as assigned
Execute commercial readiness projects and continuous improvement initiatives in preparedness for commercial manufacturing
Oversee Raw Materials staff via dotted line reporting
Create and maintain Raw Material testing schedules and metrics to ensure programs maintain a state of control and continuous material supply is met
Act as a subject matter expert (SME) and initial point of escalation for Raw Materials team members
Perform troubleshooting of processes and systems as they arise, guide team members in general troubleshooting, as applicable
Executes other QA/QC responsibilities, as assigned
Provide support for regulatory preparations and inspections
Independently completes all aspects of supplier audits and internal audits, including, but not limited to, scheduling, documentation preparation, SME coordination, hosting, follow-up responses, and audit closure
Partners with area leaders and subject matter experts for audit activities
Provides audit and inspection training as needed
Other duties, as assigned
Qualification
Required
High School or GED required, Bachelor's Degree, preferred
5-7 years of experience in Quality within the biotechnology, pharmaceutical, or medical device field, required
Minimum 4 years of experience in Raw Material programs, required
Strong understanding of regulations and compendial guidance for Raw Material program applications, including USP, EudraLex, PDA technical reports, FDA Guidance for Industry
Strong understanding of QC Raw Material testing requirements for biological products and application for in-house and outsourced laboratories
Cross-functional communication and third-party vendor communication is a critical aspect of this position
General understanding of nature and application of U.S. FDA and European regulations with respect to aseptic processing, biologics manufacturing, and human cell and tissue-based products, including but not limited to: 21 CFR Parts 11, 210, 211, 600, 820, and 1271; and relevant European Directives (2004/23/EC, 2006/17/EC, 2006/86/EC and 2012/39/EU)
Understanding of cGMP compliance in the biotech/bioprocessing manufacturing environment
Strong understanding of root cause analysis; change control requirements; Deviation/CAPA and other fundamental elements of Quality Systems
Position may require working holidays, weekends, and over-time
May be required to regularly to sit; stand for prolonged periods of time
May spend time in a manufacturing operations environment and will be required to meet applicable gowning and personal protective equipment guidelines, as applicable
Preferred
Prior experience supporting regulatory inspections a plus
Benefits
Stock Options
401k Plan with 4% Match and no Vesting Schedule
Medical, Vision and Dental Plans
Company Paid Long Term/Short Term Disability
Company Paid Life Insurance
23 Days Paid Time Off (PTO)
10 Company Designated Holidays + 2 Floating Holidays
Paid Parental Leave Policies
Company
Humacyte
Humacyte develops products for vascular diseases and replacement of anatomical conduits.
Funding
Current Stage
Public CompanyTotal Funding
$935.56MKey Investors
Avenue Capital GroupSilicon Valley BankFresenius Medical Care
2025-12-16Post Ipo Debt· $77.5M
2025-10-07Post Ipo Equity· $60M
2025-03-25Post Ipo Equity· $50M
Leadership Team
Recent News
2026-01-05
Longevity.Technology - Latest News, Opinions, Analysis and Research
2025-12-24
Company data provided by crunchbase